Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 16 Mar 2023
In Part 1 of the Obesity Series, Katherine H. Saunders, MD, DABOM discusses ways to treat childhood obesity, including the benefits of FDA-approved drugs and Intellihealth.
Read Full NewsIn high-risk low-grade glioma, starting with temozolomide or radiotherapy yields similar survival.
Researchers aim to evaluate the effectiveness of ASCT as consolidation therapy for patients with advanced-stage natural killer/T-cell lymphoma who have attained their first complete remission.
1.
A new device enhances liquid biopsy.
2.
Decrease seen in in situ breast cancer since 2009
3.
For elderly, unfit patients, the all-oral AML regimen shows promise.
4.
Five new papers highlight cancer inequities, challenges and opportunities in South Asia
5.
Guidelines for patient training and radiation protection for patients treated with radioactive iodine for thyroid cancer
1.
Sorafenib: Understanding the science behind a powerful cancer drug
2.
Cancer Prevention Through Early Immune Surveillance Enhancement
3.
The Danger of Methemoglobinemia and How to Prevent It
4.
Bispecific Antibodies in DLBCL & Myeloma: Clinical Insights for Physicians
5.
Evolution of Cancer Care Through Developmental Therapeutics
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients
2.
From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective
5.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge